Skip links

PYQUVI™ (deflazacort)

Full Name PYQUVI™ (deflazacort)
Drug deflazacort (oral suspension)
Manufacturer Aucta Pharmaceuticals, Inc
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Enrollment Form
Phone Number 847-393-4099
Fax Number 877-860-1978
Patient Resources Alex Rezcalla Foundation, Jett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy